Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial

TOGETHER investigated whether targeting multiple cardiovascular (CV) risk factors using single-pill amlodipine/atorvastatin (AML/ATO) and therapeutic lifestyle changes (TLC) results in greater blood pressure (BP)/lipid control and additional reduction in estimated cardiovascular disease (CVD) risk c...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimm, Richard, Malik, Mobin, Yunis, Carla, Sutradhar, Santosh, Kursun, Attila
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868347/
https://www.ncbi.nlm.nih.gov/pubmed/20479948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868347/
https://www.ncbi.nlm.nih.gov/pubmed/20479948

Ejemplares similares